Arkolith/Insider Trading/ATRA/Form 4

Huang James

Director, 10% OwnerAtara Biotherapeutics, Inc. (ATRA) · full profile →Form 4 · filed Jul 21, 2025
Net Buying
Open-Market Buys
$186K
Open-Market Sells
$0
Net Open-Market Flow
$186K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 17, 2025Buy(P)19K$9.64$186K1.4M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-097087) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML